Literature DB >> 23269521

Impaired mitochondrial metabolism and mammary carcinogenesis.

Nagendra Yadava1, Sallie S Schneider, D Joseph Jerry, Chul Kim.   

Abstract

Mitochondrial oxidative metabolism plays a key role in meeting energetic demands of cells by oxidative phosphorylation (OxPhos). Here, we have briefly discussed (a) the dynamic relationship that exists among glycolysis, the tricarboxylic acid (TCA) cycle, and OxPhos; (b) the evidence of impaired OxPhos (i.e. mitochondrial dysfunction) in breast cancer; (c) the mechanisms by which mitochondrial dysfunction can predispose to cancer; and (d) the effects of host and environmental factors that can negatively affect mitochondrial function. We propose that impaired OxPhos could increase susceptibility to breast cancer via suppression of the p53 pathway, which plays a critical role in preventing tumorigenesis. OxPhos is sensitive to a large number of factors intrinsic to the host (e.g. inflammation) as well as environmental exposures (e.g. pesticides, herbicides and other compounds). Polymorphisms in over 143 genes can also influence the OxPhos system. Therefore, declining mitochondrial oxidative metabolism with age due to host and environmental exposures could be a common mechanism predisposing to cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269521      PMCID: PMC3581737          DOI: 10.1007/s10911-012-9271-3

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  182 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Estrogen receptor positive breast cancers and their association with environmental factors.

Authors:  Sophie St-Hilaire; Rakesh Mandal; Amy Commendador; Sylvio Mannel; DeWayne Derryberry
Journal:  Int J Health Geogr       Date:  2011-05-10       Impact factor: 3.918

Review 3.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 4.  Chronic inflammation and cancer: the role of the mitochondria.

Authors:  David W Kamp; Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2011-04-30       Impact factor: 2.990

5.  Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions.

Authors:  Casey L Quinlan; Adam L Orr; Irina V Perevoshchikova; Jason R Treberg; Brian A Ackrell; Martin D Brand
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

Review 6.  Mitochondrial regulation of epigenetics and its role in human diseases.

Authors:  Sheroy Minocherhomji; Trygve O Tollefsbol; Keshav K Singh
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

7.  A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease.

Authors:  Prasanth Potluri; Antonio Davila; Eduardo Ruiz-Pesini; Dan Mishmar; Sean O'Hearn; Saege Hancock; Mariella Simon; Immo E Scheffler; Douglas C Wallace; Vincent Procaccio
Journal:  Mol Genet Metab       Date:  2009-01-29       Impact factor: 4.797

8.  The innate immune system in host mice targets cells with allogenic mitochondrial DNA.

Authors:  Kaori Ishikawa; Noriko Toyama-Sorimachi; Kazuto Nakada; Mami Morimoto; Hirotake Imanishi; Mariko Yoshizaki; Shigemi Sasawatari; Mamoru Niikura; Keizo Takenaga; Hiromichi Yonekawa; Jun-Ichi Hayashi
Journal:  J Exp Med       Date:  2010-10-11       Impact factor: 14.307

9.  SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis.

Authors:  Marcia C Haigis; Chu-Xia Deng; Lydia W S Finley; Hyun-Seok Kim; David Gius
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

10.  Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan.

Authors:  P-L Chen; C-F Chen; Y Chen; X E Guo; C-K Huang; J-Y Shew; R L Reddick; D C Wallace; W-H Lee
Journal:  Oncogene       Date:  2012-05-07       Impact factor: 9.867

View more
  10 in total

1.  Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.

Authors:  Hua Zhao; Jie Shen; Steven C Moore; Yuanqing Ye; Xifeng Wu; Francisco J Esteva; Debasish Tripathy; Wong-Ho Chow
Journal:  Breast Cancer Res Treat       Date:  2019-02-15       Impact factor: 4.872

Review 2.  Weight gain following breast cancer diagnosis: Implication and proposed mechanisms.

Authors:  Grace Makari-Judson; Barry Braun; D Joseph Jerry; Wilson C Mertens
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  The molecular basis of breast cancer pathological phenotypes.

Authors:  Yujing J Heng; Susan C Lester; Gary Mk Tse; Rachel E Factor; Kimberly H Allison; Laura C Collins; Yunn-Yi Chen; Kristin C Jensen; Nicole B Johnson; Jong Cheol Jeong; Rahi Punjabi; Sandra J Shin; Kamaljeet Singh; Gregor Krings; David A Eberhard; Puay Hoon Tan; Konstanty Korski; Frederic M Waldman; David A Gutman; Melinda Sanders; Jorge S Reis-Filho; Sydney R Flanagan; Deena Ma Gendoo; Gregory M Chen; Benjamin Haibe-Kains; Giovanni Ciriello; Katherine A Hoadley; Charles M Perou; Andrew H Beck
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

Review 4.  Restoration of mitochondria function as a target for cancer therapy.

Authors:  Tariq A Bhat; Sandeep Kumar; Ajay K Chaudhary; Neelu Yadav; Dhyan Chandra
Journal:  Drug Discov Today       Date:  2015-03-09       Impact factor: 7.851

Review 5.  Mitochondrial DNA mutations and breast tumorigenesis.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Biochim Biophys Acta       Date:  2013-10-16

6.  Cancer stem cell theory and the warburg effect, two sides of the same coin?

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2014-05-19       Impact factor: 5.923

Review 7.  Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Fabrizio Gentile; Stefania Pizzimenti; Rosa Angela Canuto; Martina Daga; Alessia Arcaro; Giovanni Paolo Cetrangolo; Alessio Lepore; Carlo Ferretti; Chiara Dianzani; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2016-02-19

8.  Individual-specific variation in the respiratory activities of HMECs and their bioenergetic response to IGF1 and TNFα.

Authors:  Sallie S Schneider; Elizabeth M Henchey; Nazneen Sultana; Stephanie M Morin; D Joseph Jerry; Grace Makari-Judson; Giovanna M Crisi; Richard B Arenas; Melissa Johnson; Holly S Mason; Nagendra Yadava
Journal:  J Cell Physiol       Date:  2017-05-15       Impact factor: 6.384

9.  Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy.

Authors:  Tarek Zaidieh; James R Smith; Karen E Ball; Qian An
Journal:  BMC Cancer       Date:  2021-04-17       Impact factor: 4.430

Review 10.  Putative role of adipose tissue in growth and metabolism of colon cancer cells.

Authors:  Betty Schwartz; Einav Yehuda-Shnaidman
Journal:  Front Oncol       Date:  2014-06-26       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.